Cargando…
Chemistry, structure and function of approved oligonucleotide therapeutics
Eighteen nucleic acid therapeutics have been approved for treatment of various diseases in the last 25 years. Their modes of action include antisense oligonucleotides (ASOs), splice-switching oligonucleotides (SSOs), RNA interference (RNAi) and an RNA aptamer against a protein. Among the diseases ta...
Autores principales: | Egli, Martin, Manoharan, Muthiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085713/ https://www.ncbi.nlm.nih.gov/pubmed/36881759 http://dx.doi.org/10.1093/nar/gkad067 |
Ejemplares similares
-
Acyclic (S)-glycol nucleic acid (S-GNA) modification of siRNAs improves the safety of RNAi therapeutics while maintaining potency
por: Egli, Martin, et al.
Publicado: (2023) -
Future directions for medicinal chemistry in the field of oligonucleotide therapeutics
por: Hall, Jonathan
Publicado: (2023) -
Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides
por: Juliano, Rudolph L
Publicado: (2020) -
Chemical biology and medicinal chemistry of RNA methyltransferases
por: Fischer, Tim R, et al.
Publicado: (2022) -
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
por: Terada, Chisato, et al.
Publicado: (2022)